Arecor Therapeutics plc (LON:AREC – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 130 ($1.62) and last traded at GBX 130.24 ($1.62), with a volume of 16323 shares changing hands. The stock had previously closed at GBX 132.50 ($1.65).
Arecor Therapeutics Stock Down 1.2 %
The company has a debt-to-equity ratio of 1.26, a quick ratio of 6.24 and a current ratio of 2.52. The stock has a market cap of £39.36 million, a P/E ratio of -414.52 and a beta of -0.22. The stock’s fifty day simple moving average is GBX 142.73 and its 200-day simple moving average is GBX 168.33.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- The How and Why of Investing in Biotech Stocks
- What’s Driving Tesla Lower Ahead of its Earnings?
- How to Use Stock Screeners to Find Stocks
- Here are the Pros and Cons of Using Options Put Credit Spreads
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Can Netflix Stock Continue Into All-Time Highs After Earnings?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
